28226-22-4

Basic information

• Product Name: 6-NITRO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE
• Synonyms: 6-NITRO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE;6-NITRO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE HYDROCHLORIDE;6-NITRO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE;3,4-Dihydro-6-nitro-2H-benzo[B][1,4]-oxazine;6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride;6-Nitro-3,4-dihydro-2H-benzo[1,4]oxazine 1HCl salt;6-nitro-1,4-benzoxazine
• CAS NO: 28226-22-4
• Molecular Formula: C₈H₈N₂O₃
• Molecular Weight: 180.16
• Mol File: 28226-22-4.mol
• Article Data: 3

Chemical Properties

• Melting Point: 117-119°
• Boiling Point: 337.1 °C at 760 mmHg
• Flash Point: 157.7 °C
• Appearance: /
• Density: 1.332 g/cm³
• Vapor Pressure: 0.000107mmHg at 25°C
• Refractive Index: 1.585
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.67±0.20(Predicted)
• CAS DataBase Reference: 6-NITRO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-NITRO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE(28226-22-4)
• EPA Substance Registry System: 6-NITRO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE(28226-22-4)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1 / PGIII
• HazardClass: IRRITANT
• Hazardous Substances Data: 28226-22-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H8N2O3/c11-10(12)6-1-2-8-7(5-6)9-3-4-13-8/h1-2,5,9H,3-4H2

Upstream product

• 98395-62-1 1-amino-2-(4-nitrophenoxy)ethane hydrochloride 
• 108-24-7 acetic anhydride 
• 5735-53-5 1,4-benzoxazine 

Downstream Products

• 107754-42-7 methyl 3-methoxy-4-<(6-nitro-2,3-dihydrobenz-1,4-oxazin-4-yl)methyl>benzoate 
• 26011-57-4 3,4-Dihydro-2H-benzo[1,4]oxazin-6-ylamine 
• 193401-76-2 4-benzyloxybutanal, 4-amino-2,3-dihydro-6-nitro-1,4-benzoxazine hydrazone 
• 226571-61-5 3,4-dihydro-4-methyl-6-amino-1,4-benzoxazine 
• 120711-72-0 3,4-dihydro-6-(2-imidazolin-2-ylamino)-4-methyl-2H-1,4-benzoxazine hydroiodide 
• 120711-73-1 3,4-dihydro-6-(2-imidazolin-2-ylamino)-2H-1,4-benzoxazine-4-carbaldehyde hydroiodide 
• 107754-41-6 methyl 4-<(6-amino-2,3-dihydrobenz-1,4-oxazin-4-yl)methyl>-3-methoxybenzoate 
• 107786-70-9 4-<<6-(2-cyclopentylacetamido)-2,3-dihydrobenz-1,4-oxazin-4-yl>methyl>-3-methoxybenzoic acid 
• 107786-69-6 methyl 4-<<6-(2-cyclopentylacetamido)-2,3-dihydrobenz-1,4-oxazin-4-yl>methyl>-3-methoxybenzoate 
• 107754-45-0 4-<<6-<<(cyclopentyloxy)carbonyl>amino>-2,3-dihydrobenz-1,4-oxazin-4-yl>methyl>-3-methoxybenzoic acid 
• 107754-44-9 methyl 4-<<6-<<(cyclopentyloxy)carbonyl>amino>-2,3-dihydrobenz-1,4-oxazin-4-yl>methyl>-3-methoxybenzoate 
• 107754-48-3 N-[4-[6-(cyclopentyloxycarbonyl)amino-2,3-dihydrobenz-1,4-oxazin-4-ylmethyl]-3-methoxybenzoyl]benzenesulphonamide 
• 107786-89-0 N-[4-[6-(2-cyclopentylacetamido)-2,3-dihydrobenz-1,4-oxazin-4-ylmethyl]-3-methoxybenzoyl]-2-methylbenzenesulphonamide 
• 928118-23-4 tert-butyl 6-nitro-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate 

Relevant articles and documents

Guanidine compound for preventing and treating chronic pain medication (by machine translation)

The invention relates to a guanidine compound as shown in general formula (I) as a guanidine compound for preventing and treating chronic pain disease. A pharmaceutically acceptable salt thereof, a prodrug thereof, a solvate thereof, a deuterated substanc

Thermal and Photochemical Smiles Rearrangement of β-(Nitrophenoxy)ethylamines

-